Nanalysis Scientific Corp
XTSX:NSCI
Intrinsic Value
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation mar... [ Read More ]
The intrinsic value of one
NSCI
stock under the Base Case scenario is
0.37
CAD.
Compared to the current market price of 0.45 CAD,
Nanalysis Scientific Corp
is
Overvalued by 18%.
Nanalysis Scientific Corp's market capitalization is 45.6m CAD.
NSCI stock price is 0.45 CAD.
NSCI stock (0.37 CAD) is 18% less than its price (0.45 CAD).
NSCI has upside potential of 172% compared to the average analyst price target.
Open Wall St Estimates
NSCI's Revenue has grown by an exceptional 35% over the past 12 months.
NSCI's short-term assets (16m CAD) exceed its short-term liabilties (11m CAD).
NSCI's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -22% to -37%, and is approaching profitability.
NSCI's ROE (Return on Equity) has significantly decreased in the last 3 years from -19% to -70%, and is approaching profitability.
NSCI's long-term assets (53m CAD) exceed its long-term liabilties (27m CAD).
NSCI's D/E (Debt to Equity) is very low and is equal to 0.57.
NSCI has negative Operating Income for the last twelve months.
NSCI has negative Net Income for the last twelve months.
NSCI's ROE (Return on Equity) for the past 12 months is negative and is equal to -70%.
NSCI's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -37%.
NSCI has positive Gross Profit for the last twelve months.
NSCI's Revenue has been growing by an exceptional 51% per year for the last 3 years.
NSCI has negative Free Cash Flow for the last twelve months.
NSCI has positive Net Debt. This means that the company has more debt (15m CAD) than cash and short-term investments (1m CAD).
NSCI has negative three-year average ROE (Return on Equity): -26%. The company is not efficient at transforming stockholders' equity into net income.
NSCI has negative three-year average ROIC (Return on Invested Capital): -23%. The company is not efficient at using invested capital to generate operating income.
NSCI's Altman Z-Score is very low and is equal to -0.42.
Valuation Backtest
Nanalysis Scientific Corp
Run backtest to discover the historical profit from buying and selling
NSCI
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Nanalysis Scientific Corp
Balance Sheet Decomposition
Nanalysis Scientific Corp
| Current Assets | 16.4m |
| Cash & Short-Term Investments | 1.3m |
| Receivables | 6.5m |
| Other Current Assets | 8.6m |
| Non-Current Assets | 36.2m |
| Long-Term Investments | 6m |
| PP&E | 4.4m |
| Intangibles | 21.6m |
| Other Non-Current Assets | 4.2m |
| Current Liabilities | 10.8m |
| Accounts Payable | 4.7m |
| Other Current Liabilities | 6.1m |
| Non-Current Liabilities | 16.4m |
| Long-Term Debt | 14.5m |
| Other Non-Current Liabilities | 1.9m |
Earnings Waterfall
Nanalysis Scientific Corp
|
Revenue
|
30.5m
CAD
|
|
Cost of Revenue
|
-26.3m
CAD
|
|
Gross Profit
|
4.2m
CAD
|
|
Operating Expenses
|
-24.9m
CAD
|
|
Operating Income
|
-20.7m
CAD
|
|
Other Expenses
|
-957k
CAD
|
|
Net Income
|
-21.7m
CAD
|
Free Cash Flow Analysis
Nanalysis Scientific Corp
NSCI Profitability Score
Profitability Due Diligence
Nanalysis Scientific Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
Score
Nanalysis Scientific Corp's profitability score is 25/100. The higher the profitability score, the more profitable the company is.
NSCI Solvency Score
Solvency Due Diligence
Nanalysis Scientific Corp's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Score
Nanalysis Scientific Corp's solvency score is 41/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSCI Price Targets Summary
Nanalysis Scientific Corp
According to Wall Street analysts, the average 1-year price target for
NSCI
is 1.22 CAD
with a low forecast of 1.21 CAD and a high forecast of 1.26 CAD.
Shareholder Return
NSCI Price
Nanalysis Scientific Corp
| Average Annual Return | 31.23% |
| Standard Deviation of Annual Returns | 102.75% |
| Max Drawdown | -79% |
| Market Capitalization | 45.6m CAD |
| Shares Outstanding | 101 425 441 |
| Percentage of Shares Shorted | 0.17% |
Company Profile
Nanalysis Scientific Corp
Country
Industry
Market Cap
Dividend Yield
Description
Nanalysis Scientific Corp. is a capital pool company, which engages in the development and manufacture of portable nuclear magnetic resonance (NMR) spectrometers for the laboratory instrumentation market. The company is headquartered in Calgary, Alberta. The company went IPO on 2017-06-29. The firm operates through three segments: Nanalysis, RS2D and Corporate. Through its European subsidiary RS2D S.A.S. (RS2D), the Company also manufactures and distributes electronic boards and software are used in nuclear magnetic resonance (NMR) and MRI equipment. Its 60 and 100 megahertz (MHz) spectrometers incorporate permanent magnets and require no liquid helium or other cryogens. Its spectrometers are used by chemical professionals spanning industries, including oil and gas, chemical, mining, pharmaceutical, and biotechnology. The Company’s product offerings are based upon its magnet technology, as well as its Cam4 technology.
Contact
IPO
Employees
Officers
The intrinsic value of one
NSCI
stock under the Base Case scenario is
0.37
CAD.
Compared to the current market price of 0.45 CAD,
Nanalysis Scientific Corp
is
Overvalued by 18%.
You don't have any saved screeners yet
